These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 8737541)
21. Microalbuminuria and associated factors in newly diagnosed diabetics. Unuigbe EI; Omeife H; Edema T; Ukoli FA Niger Postgrad Med J; 2001 Dec; 8(4):187-92. PubMed ID: 11922026 [TBL] [Abstract][Full Text] [Related]
22. [Microalbuminuria--a risk indicator for the development of nephropathy in insulin-dependent diabetics]. Dryáková M; Englis M; Bartos V; Rozprimová L; Sidlová A; Malý J Cas Lek Cesk; 1989 Oct; 128(43-44):1372-6. PubMed ID: 2598252 [TBL] [Abstract][Full Text] [Related]
23. Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy. Parving HH J Hypertens Suppl; 1998 Jan; 16(1):S99-101. PubMed ID: 9534107 [TBL] [Abstract][Full Text] [Related]
24. [Antihypertensive therapy in diabetes mellitus]. Hess B Ther Umsch; 1999 Jan; 56(1):25-32. PubMed ID: 10067131 [TBL] [Abstract][Full Text] [Related]
25. Microalbuminuria--a marker of the risk of developing nephropathy in insulin-dependent diabetes. Dryáková M; Englis M; Bartos V; Rozprimová L; Sidlová A; Malý J Czech Med; 1989; 12(3):181-8. PubMed ID: 2509176 [TBL] [Abstract][Full Text] [Related]
26. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine. Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038 [TBL] [Abstract][Full Text] [Related]
27. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus. Wang QY; Chen FQ Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668 [TBL] [Abstract][Full Text] [Related]
28. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Comper WD; Osicka TM; Clark M; MacIsaac RJ; Jerums G Kidney Int; 2004 May; 65(5):1850-5. PubMed ID: 15086926 [TBL] [Abstract][Full Text] [Related]
29. Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus. Molnár M; Wittmann I; Nagy J Med Sci Monit; 2000; 6(5):929-36. PubMed ID: 11208433 [TBL] [Abstract][Full Text] [Related]
30. Predicting diabetic nephropathy in insulin-dependent patients. Mogensen CE; Christensen CK N Engl J Med; 1984 Jul; 311(2):89-93. PubMed ID: 6738599 [TBL] [Abstract][Full Text] [Related]
35. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Mathiesen ER; Oxenbøll B; Johansen K; Svendsen PA; Deckert T Diabetologia; 1984 Jun; 26(6):406-10. PubMed ID: 6468791 [TBL] [Abstract][Full Text] [Related]
36. Microalbuminuria in an adolescent cohort with insulin-dependent diabetes mellitus. Quattrin T; Waz WR; Duffy LC; Sheldon MW; Campos SP; Albini CH; Feld LG Clin Pediatr (Phila); 1995 Jan; 34(1):12-7. PubMed ID: 7720322 [TBL] [Abstract][Full Text] [Related]
37. Microalbuminuria as a risk predictor in diabetes: the continuing saga. Bakris GL; Molitch M Diabetes Care; 2014; 37(3):867-75. PubMed ID: 24558077 [TBL] [Abstract][Full Text] [Related]
39. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes. Naidoo DP Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063 [TBL] [Abstract][Full Text] [Related]
40. Urinary excretion of albumin in adolescents with type 1 diabetes: persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. Holl RW; Grabert M; Thon A; Heinze E Diabetes Care; 1999 Sep; 22(9):1555-60. PubMed ID: 10480525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]